SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

KNSA Q3'26 Earnings Preview: EPS Estimate 0.37 USD

Kiniksa Pharmaceuticals is set to report Q3'26 results on October 27 before the market opens. Revenue is estimated at 260.66 million USD, with EPS anticipated at 0.37 USD.

KNSA

Related stories